A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis2018-01-17T17:00:50-05:00